These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21866037)

  • 1. Role of nuclear factor of activated T cell (NFAT) transcription factors in skin and vascularized cardiac allograft rejection.
    Ueno T; Yamada A; Ito T; Yeung MY; Gorbatov R; Shimizu T; Abdi R; Sayegh MH; Auchincloss H; Najafian N
    Transplantation; 2011 Sep; 92(5):e26-7. PubMed ID: 21866037
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac and skin xenograft survival in different recipient mouse strains.
    Gock H; Murray-Segal L; Salvaris E; Fisicaro N; Cowan PJ; d'Apice AJ
    Transplantation; 2006 Nov; 82(10):1362-9. PubMed ID: 17130786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evidence for the Th1/Th2 paradigm: oral alloantigen-induced modulation of accelerated allograft rejection is associated with dense intragraft IL-4.
    Hancock WW; Sayegh MH; Carpenter CB
    Transplant Proc; 1992 Oct; 24(5):2313-4. PubMed ID: 1413074
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of cytokine functions in graft rejection by gene expression profiles.
    Liang Y; Christopher K; DeFina R; Cidado J; He H; Haley KJ; Finn PW; Perkins DL
    Transplantation; 2003 Dec; 76(12):1749-58. PubMed ID: 14688527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CD4+ and CD8+ T cells in murine skin and heart allograft rejection across different antigenic desparities.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Immunol; 2004 Dec; 13(4):297-304. PubMed ID: 15589743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of nitric oxide during graft rejection is regulated by the Th1/Th2 balance, the arginase activity, and L-arginine metabolism.
    Holán V; Pindjáková J; Krulová M; Neuwirth A; Fric J; Zajícová A
    Transplantation; 2006 Jun; 81(12):1708-15. PubMed ID: 16794538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway.
    Wu T; Sun C; Chen Z; Zhen Y; Peng J; Qi Z; Yang X; Zhao Y
    J Immunol; 2012 Nov; 189(10):4989-5000. PubMed ID: 23045614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33 prolongs murine cardiac allograft survival through induction of TH2-type immune deviation.
    Yin H; Li XY; Jin XB; Zhang BB; Gong Q; Yang H; Zheng F; Gong FL; Zhu JY
    Transplantation; 2010 May; 89(10):1189-97. PubMed ID: 20220570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
    Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of regulatory T cells and indefinite survival of fully allogeneic cardiac grafts by ursodeoxycholic acid in mice.
    Zhang Q; Nakaki T; Iwami D; Niimi M; Shirasugi N
    Transplantation; 2009 Dec; 88(12):1360-70. PubMed ID: 20029332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.
    Krieger NR; Fathman CG
    J Heart Lung Transplant; 1997 Mar; 16(3):263-7. PubMed ID: 9087868
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation.
    de Moraes LV; Bueno V; Marguti I; Martins GA; Vallochi AL; Yamamoto GL; Panajotopoulos N; Mengel JO; Rizzo LV
    Transpl Immunol; 2008 Feb; 18(4):330-7. PubMed ID: 18158119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
    Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
    Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
    Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
    Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effector mechanisms in murine allograft rejection: comparison of skin and heart grafts in fully allogeneic and minor histocompatibility antigen-mismatched strain combinations.
    Youssef AR; Otley C; Mathieson PW; Smith RM
    Transpl Int; 2002 Jun; 15(6):302-9. PubMed ID: 12072901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac allograft rejection in the absence of macrophage migration inhibitory factor.
    Demir Y; Chen Y; Metz C; Renz H; Heeger PS
    Transplantation; 2003 Jul; 76(1):244-7. PubMed ID: 12865817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.